Genomics, microbiomics, proteomics, and metabolomics in bronchopulmonary dysplasia.

Academic Article

Abstract

  • Bronchopulmonary Dysplasia (BPD) is a disorder with a multifactorial etiology and highly variable clinical phenotype. Several traditional biomarkers have been identified, but due to the complex disease phenotype, these biomarkers have low predictive accuracy for BPD. In recent years, newer technologies have facilitated the in-depth and unbiased analysis of 'big data' in delineating the diagnosis, pathogenesis, and mechanisms of diseases. Novel systems-biology based 'omic' approaches, including but not limited to genomics, microbiomics, proteomics, and metabolomics may help define the multiple cellular and humoral interactions that regulate normal as well as abnormal lung development and response to injury that are the hallmarks of BPD.
  • Published In

    Keywords

  • BPD, Genetics, Metabolome, Microbiome, Proteome, Systems biology
  • Digital Object Identifier (doi)

    Author List

  • Lal CV; Bhandari V; Ambalavanan N
  • Start Page

  • 425
  • End Page

  • 431
  • Volume

  • 42
  • Issue

  • 7